Genome sequencing can report health findings you did not ask about. Learn what secondary findings are, what the ACMG list covers and how to decide first.
Saliva, blood and cheek swabs can all yield usable DNA, but they differ in failure rates, bacterial contamination and edge cases. Here is what the data show.
Twelve provider-neutral questions to ask before buying whole genome sequencing, from raw file access and reference build to data deletion and reanalysis.
A polygenic risk score adds up many small DNA effects into one number. See how it is built, why it is relative and ancestry-dependent, and how to read yours.
Your genome files can run to hundreds of gigabytes. Here is how to download, verify, shrink, encrypt and back them up so you never lose or leak them.
How police use DNA databases to find suspects through relatives, which services allow it, what federal and state rules say, and how to check your settings.
What to bring, how to frame the question and what to expect when you show a doctor consumer DNA results, including why a clinical confirmation test is common.
Haplogroups trace a single paternal (Y-DNA) or maternal (mtDNA) line far back in time. Learn what the letters mean, what they reveal, and what they cannot.
Eight common beliefs about DNA tests, from "genes are destiny" to "a clean report means no risk," and what the evidence says instead.
GRCh37 (hg19) and GRCh38 (hg38) use different coordinates, so mixing them breaks tools. See how to check your file’s build and what to do if it is wrong.
Third-party tools can flag frightening variants in your raw DNA data that clinical testing later fails to confirm. Here is why, and how to triage a scary hit.
What a genetic counselor does, the situations when seeing one before or after testing makes sense, what a session covers and how to find one and prepare.
Whole exome sequencing covers about 1.5-2% of your DNA. Whole genome sequencing covers all of it. Here
Exome sequencing reads ~1-2% of your genome; whole genome reads it all. Here
From ACTN3 muscle fiber typing to pharmacogenomics for pain medication and recovery, here
VKORC1 and CYP2C9 together explain a large share of the huge person-to-person variation in warfarin dose. Genotype-guided dosing is FDA-labeled.
VUS is the most common — and most confusing — result category in genetic testing. More than half of all identified variants fall into it. Here
TCF7L2 is the strongest common genetic risk factor for type 2 diabetes. But it
Most consumer DNA tests only look for single-letter changes in your DNA. Structural variants and copy number variations are a completely different, often-missed category of mutation.
A single SLCO1B1 variant markedly raises statin exposure and the risk of muscle side effects. CPIC has published dosing guidance based on it.
Twin studies put chronotype heritability at roughly 40-50%. PER3, CLOCK, and CRY1 gene variants shape whether you
Our honest Sequencing.com review covers the $399 whole genome sequencing kit, the DNA app marketplace, hidden costs, data delivery, and how it compares to Dante Labs and DNA Complete in…
Adverse drug reactions are the 4th leading cause of death in the US. 30–60% are preventable with pharmacogenomic testing. Your DNA determines which medications help, which do nothing, and…
LRRK2 and GBA are the two most important genes in Parkinson
Your CYP1A2 gene determines whether coffee protects your heart or strains it. Your ACTN3 gene shapes whether you
The UK, US and others are piloting whole genome sequencing at birth to screen for hundreds of treatable conditions. Here
The UK is rolling out whole genome sequencing for every newborn starting in 2026. Pilot studies found 1 in 200 babies carry a rare, treatable condition standard screening misses. Here
Male pattern baldness is about 80% heritable — one of the most heritable traits in human genetics. But the
The AR gene on the X chromosome matters, but hair loss is highly polygenic. Here
Lynch syndrome is the most common hereditary cancer predisposition syndrome, raising colorectal and endometrial cancer risk dramatically — and most carriers don
Long QT syndrome affects roughly 1 in 2,000 people and can cause fainting or sudden cardiac death — often in young, otherwise-healthy individuals. Genetics can flag it.
Unlike health insurance, life insurers can legally ask about and use your genetic test results in underwriting. Here
Most humans on Earth lose the ability to digest lactose after childhood — being able to drink milk as an adult is the genetic exception, not the rule. Here
Whether you can digest lactose as an adult comes down to a single regulatory variant near the LCT gene — and it
Ordering a DNA test kit from outside the US? Here
Why do siblings get different ancestry percentages from the same test? Why does your result change when a company updates its algorithm? Here
HLA-B27 is present in roughly 5-9% of the general population but up to 90% of people with ankylosing spondylitis. Here
Hemochromatosis from HFE C282Y variants is one of the most common inherited disorders in people of European descent — and one of the most treatable. Here
Hereditary hemochromatosis is one of the most common genetic conditions in people of Northern European descent — and one of the few you can treat with something as simple as donating blood…
The Genetic Information Nondiscrimination Act protects you from genetic discrimination in health insurance and employment — but not in the three places most people assume it does.
The average rare disease diagnosis takes 5-8 years. Some families wait 30. Whole genome sequencing is replacing years of sequential testing with a single, comprehensive answer.
80% of children born with genetic disorders have no family history. Carrier screening before pregnancy reveals hidden risks. Here
A step-by-step guide to pre-conception genetic testing for couples. What carrier screening is, how to get tested, how to read results, how to find a genetic counselor, and what your options…
FTO gets called
FOXO3 is the second most replicated longevity gene in human genetics, identified across centenarian studies on nearly every continent. Here
A major FDA rule that would have reshaped genetic testing oversight was vacated by a federal court in 2025, and the FDA chose not to appeal. Here
Familial hypercholesterolemia is one of the most common serious genetic conditions in the world — and one of the most underdiagnosed. Here
FH affects roughly 1 in 250 people and is dramatically underdiagnosed. A genetic answer can reshape how aggressively your cholesterol is treated — decades earlier.
Factor V Leiden is the most common inherited clotting disorder, carried by around 1 in 20 people of European descent. Here
Factor V Leiden is the most common inherited clotting disorder, carried by up to 1 in 20 people of European descent. Here
Eye color isn
Identical twins share nearly 100% of their DNA, yet age, get sick, and look different over time. Epigenetics — not genetics — explains why. Here
Not all genetic tests carry the same weight. Here
A DPYD variant can make routine fluoropyrimidine chemotherapy fatal. Regulators now recommend testing before treatment — here
The COMT Val158Met polymorphism determines how fast your brain clears dopamine. Learn what warrior vs. worrier really means, what rs4680 says about stress, focus, and pain — and what the…
Clopidogrel needs CYP2C19 to activate. Poor metabolizers get little benefit — an FDA boxed-warning issue that genetic testing can flag before a stent fails.
Your natural sleep timing is partly heritable, shaped by clock genes like PER2, PER3 and CLOCK. A rare variant even causes lifelong extreme early rising.
A 32-base-pair deletion in CCR5 blocks the doorway most HIV uses to enter cells. It
If you only care about health, carrier status, and pharmacogenomics — not ancestry breakdowns — here
AncestryDNA, 23andMe, FamilyTreeDNA, MyHeritage, and whole genome sequencing compared honestly. Which ancestry DNA test is actually worth your money in 2026?
The APOE gene is the strongest genetic risk factor for late-onset Alzheimer
CYP2C19 and CYP2D6 shape how your body handles many antidepressants. Genetics won
Alpha-1 antitrypsin deficiency is frequently misdiagnosed as ordinary COPD or asthma for years. Knowing your SERPINA1 status changes prevention and treatment.
Alcohol flush reaction affects roughly 540 million people worldwide and isn
The alcohol flush reaction is caused by an ALDH2 variant carried by hundreds of millions of people. It
ACTN3 is the most studied gene in sports genetics — and it genuinely predicts something about whether your muscles lean toward explosive power or endurance. Here
23andMe filed for bankruptcy, was acquired by TTAM Research Institute, and your DNA is under new ownership. What happened, what it means for your data, and what to do about it.
Deleting your DNA account removes a lot, not everything. See what stays behind, which laws give you leverage, and how to download and delete in the right order.
A single gene explains why Brussels sprouts taste fine to some people and unbearably bitter to others. TAS2R38 and the science of supertasting, explained.
The Human Genome Project declared success in 2003, but it left roughly 8% of the genome unread — including entire chromosome regions. The T2T-CHM13 project finally completed it in 2022. Here
Nearly everyone outside of Africa carries 1-4% Neanderthal DNA. It
You have two genomes, not one. Your mitochondrial DNA is inherited exclusively from your mother, follows completely different rules than the rest of your DNA, and can cause disease on its…
Most consumer whole genome sequencing uses short-read technology — fast, cheap, and accurate for most of the genome, but structurally blind to certain regions. Here
Nearly every consumer whole genome test uses short-read sequencing. It
Sequencing a genome takes hours. Interpreting it correctly has taken years. AI is closing that gap — from AlphaMissense
Why do some people find broccoli unbearably bitter while others barely notice? TAS2R38 explains supertasters, medium tasters, and non-tasters — and why the same vegetable can taste like two…
Most non-African people carry around 2% Neanderthal DNA. But that 2% isn
Hypertrophic cardiomyopathy is the most common inherited heart disease and a leading cause of sudden cardiac death in young athletes — and it can exist for years with zero symptoms. What…
The gene behind red hair does a lot more than pigmentation — it may change how much anesthesia you need, how you feel pain, and your melanoma risk. Here
Red hair isn
A genetic test for Huntington
G6PD deficiency affects over 400 million people worldwide, most of whom don
One SNP in the ABCC11 gene determines whether you have wet or dry earwax — and whether you have underarm body odor at all. Here
TP53 is called the guardian of the genome for a reason. A single inherited mutation causes Li-Fraumeni syndrome and pushes lifetime cancer risk as high as 90-95%. Here
TP53 mutations cause Li-Fraumeni syndrome, one of the highest hereditary cancer risks known to medicine — up to 90-95% lifetime risk. Here
Spinal muscular atrophy is the leading genetic cause of infant death — and roughly 1 in 40 to 1 in 60 people carry the SMN1 deletion without any symptoms at all. Here
Spinal muscular atrophy is the leading genetic cause of infant death — and roughly 1 in 50 people are unknowing carriers. Here
1 in 1,149 people carry a genetic variant that turns routine anesthesia into a life-threatening emergency. Most never know until they
1 in 1,149 people carry a gene variant that turns routine anesthesia into a life-threatening emergency. RYR1 and malignant hyperthermia explained — and why the ACMG recommends reporting it…
Cystic fibrosis is the most common life-shortening genetic disease in people of European descent, and roughly 1 in 25 carry a CFTR mutation with zero symptoms. Here
About 1 in 25 people of Northern European descent carry a CFTR mutation for cystic fibrosis without knowing it. Here
An HFE gene test checks for C282Y, H63D and S65C. How it differs from an iron blood test, what each genotype result means, and the transferrin saturation threshold that triggers testing.
HFE hemochromatosis is autosomal recessive - but type 4 ferroportin disease is dominant. Inheritance odds, penetrance data, and what it means for your family.
One HFE variant copy makes you a carrier, not a patient. What the research says about carrier risk, what it means for your children and siblings, and what to do if your ferritin is high…
30× coverage explained in plain language: why your genome needs to be read 30 times, what Q30 scores mean, and why coverage depth determines whether your results are clinical-grade.
Poor metabolizer, intermediate, normal, ultrarapid — what the phenotype labels on your PGx report mean, how activity scores are calculated, and why two labs can give you different answers.
Every route to an MTHFR result — clinical lab, consumer SNP chip, whole genome sequencing, and raw-data lookup — with real 2026 costs and the one thing to decide before you spend anything.
Should MTHFR carriers take L-methylfolate instead of folic acid? An honest look at the evidence, the marketing, and what health authorities recommend for folate supplementation.
Heterozygous, homozygous, compound heterozygous — what each MTHFR genotype means for enzyme activity, and which ones the ACMG says are unlikely to be clinically significant.
What the MTHFR C677T variant actually does, who carries it, what the evidence says about homocysteine and disease risk, and why every major medical body says not to test for it routinely.
The MTHFR A1298C variant reduces enzyme activity less than C677T and has weaker disease associations. Here is what the peer-reviewed evidence actually shows, and how it differs from its…
A clinical hereditary cancer panel and consumer whole genome sequencing both read cancer risk genes — but only one is built for medical decisions. Here is the honest comparison.
“Genomic testing for cancer” means two completely different tests. Germline testing looks at inherited risk; tumor profiling looks at the cancer itself. Confusing them leads to real harm.
Consumer whole genome sequencing in 2026, compared on the things that matter: coverage depth, raw file access, turnaround, data portability, and whether the company will still exist next…
Ethnicity estimates are only as good as the reference panel behind them. We compare AncestryDNA, 23andMe, MyHeritage, FamilyTreeDNA and Living DNA on the metric that actually determines…
An honest, independent review of Dante Labs whole genome sequencing in 2026. Pricing, raw data access, turnaround times, and what 100,000+ genomes taught us about this provider.
Why whole genome sequencing matters in 2026: from pharmacogenomics to rare disease detection, here are 10 evidence-based reasons to decode your complete DNA.
Whole genome sequencing vs genotyping: a data-driven comparison of what each approach captures, what it misses, and which delivers better value per dollar in 2026.
99% of people carry at least one pharmacogenomic variant. Here
Got your genome sequenced? Here
Can genome testing predict cancer? A careful look at hereditary cancer genes beyond BRCA, what WGS detects that genotyping misses, and the limits of genetic risk assessment.
Which genome testing services ship internationally? A guide for buyers in Europe, Latin America, Asia, and beyond — covering providers, legal restrictions, and shipping logistics.
What are FASTQ, BAM, and VCF files? A plain-language guide to the three raw data formats you get from whole genome sequencing — what they contain, how big they are, and what to do with them.
The MTHFR gene explained with science, not hype. What C677T and A1298C variants do, how they affect folate metabolism, and what the evidence actually says about supplementation.
Who owns your genome data? A provider-by-provider comparison of DNA data privacy policies, deletion rights, third-party sharing, and what happens when a company goes bankrupt.
23andMe vs Dante Labs: one reads 0.01% of your genome for $229, the other reads 100% for $180. A detailed comparison of coverage, data, reports, and real-world value.
Genome sequencing costs in 2026: from $79 genotyping tests to $430 whole genome sequencing, here
Dante Labs vs Sequencing.com: a head-to-head comparison of the two leading consumer whole genome sequencing providers — pricing, raw data, turnaround, and reliability.